Skip to content

A Comparative Study to see the effect of Jatiphala Lepa( Myristica fragrans ) & Arjun Twak Lepa (Terminalia arjuna)in the management of Melasma.

A Randomized Controlled Clinical Trial to evaluate the efficacy of Jatiphala Lepa (Myristica fragrans) and Arjun Twak Lepa (Terminalia arjuna) with Honey in the management of Vyanga(Melasma).

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/12/048415
Enrollment
60
Registered
2022-12-23
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L814- Other melanin hyperpigmentation

Interventions

None listed

Sponsors

Dr Megha Champati Sawle
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with signs and symptoms of vyanga- ruksha (dryness),khara, krushana varya(blackish edges),rakta varya(reddish edges), kandu (itching), daha(burning).

Exclusion criteria

Exclusion criteria: Vyanga along with kustharoga to be excluded. Hyper pigmentation caused since birth. Pregnant & lactating women.

Design outcomes

Primary

MeasureTime frame
To reduced hyperpigmentation of skin. To assess Skin Luster(Twakvaivarnta),Number of Lesion and Size of Lesion in Vyanga.Timepoint: 14 days study with 2 follow up (0,7,14)

Secondary

MeasureTime frame
To observe adverse effect,if any.Timepoint: 14 days study with 2 follow up (0,7,14)

Countries

India

Contacts

Public ContactDr Megha Champati Sawle

Dr. D. Y. Patil College of Ayurved Hospital and Research Centre

vjayu82@gmail.com8983478062

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026